The TDF lawsuit is a type of personal injury case that is looking for compensation for people who are injured by TDF drugs. Injuries caused by TDF drugs can range from muscle weakness to bone fractures. The Showard Law Firm is experienced in filing TDF's demands for individuals who have experienced side effects after taking this medication. When litigation continues, free consultation will be available. Here are some things you must know before filing a TDF lawsuit.
TDF drugs are known to cause severe bone and kidney injuries. Because Gilead knows about these risks, it does not have the means to warn doctors and patients about them. Furthermore, Gilead delayed the introduction of an un toxic alternative, producing exposure to prolonged TDF drugs. An un toxic alternative for TDF is called TAF. Because TDF is not as effective, this lawsuit is submitted in an effort to restore compensation for the victims.
The first TDF claim was submitted in the California District Court in May 2016. Since then, two TDF demands are submitted in 2018. The Superior Court San Francisco has consolidated TDF litigation to make processes faster and more efficient. The bellwether trial for 14 test cases has been scheduled for April 2022. Further Bellwether experiments are expected to provide a starting point to complete TDF's demands. This is very important because the number of TDF demands grows and the complexity of litigation will require many years to collect enough evidence to prove the company responsible.
Gilead patents at TDF are not allowed to end until 2010, when Gilead developed alternatives. Gilead was also allegedly waiting until the patent at TAF ended before releasing it to the public. This resulted in the increasing number of lawsuits against the company, and safer new drugs were finally approved by the FDA in November 2015.
There are more than 4,000 cases of TDF injuries throughout the world. The biggest TDF lawsuit was submitted in May 2018 by the AIDS Health Foundation. This case highlights the dangers associated with TDF and how the drug fails to warn people from serious side effects. The FDA also reprimanded TDF producers in 2002, but the company continued to mislead doctors about the risk of the drug. This is a pending class action lawsuit in the California District Court.
In 2001, the FDA issued a warning letter to Gilead regarding TDF marketing. The letter referred to Gilead's sales representatives suspected of making misleading statements about the safety of the drug. The FDA found that Gilead promoted Virad as a safer alternative for other HIV drugs. These statements ultimately cause an increase in recipes and sales for drugs. In fact, domestic sales from Viread reached $ 59.4 million in 2003.
While TDF-based drugs are a lifetime choice for people who live with HIV, they cause serious side effects. Gilead knows about risks associated with TDF-based drugs, but holding more effective alternatives to maximize their profits. It must stop and make Gilead responsible. So far, there are only nine lawsuits raised against TDF, with the most important creatures in New York and California.
No comments:
Post a Comment